2020
DOI: 10.1016/j.ctim.2019.102283
|View full text |Cite
|
Sign up to set email alerts
|

The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
56
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 68 publications
(65 citation statements)
references
References 33 publications
8
56
1
Order By: Relevance
“…Based on the findings of the present work, curcumin supplementation significantly improved FPG, plasma insulin levels, HOMA‐IR, QUICKI, and some lipid profiles including total‐ and LDL‐cholesterol; however, triglycerides, HDL‐, and VLDL‐cholesterol levels remained unchanged. In line with our findings, a recent meta‐analysis by Jalali et al (2020) stated that curcumin supplementation in patients with NAFLD decreased FPG, insulin levels, HOMA‐IR, total‐, and LDL‐cholesterol values. Another meta‐analysis of curcumin supplementation indicated a significant decrease of FPG, insulin resistance, and total cholesterol in patients with MetS (Fraser & Price, 1990).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Based on the findings of the present work, curcumin supplementation significantly improved FPG, plasma insulin levels, HOMA‐IR, QUICKI, and some lipid profiles including total‐ and LDL‐cholesterol; however, triglycerides, HDL‐, and VLDL‐cholesterol levels remained unchanged. In line with our findings, a recent meta‐analysis by Jalali et al (2020) stated that curcumin supplementation in patients with NAFLD decreased FPG, insulin levels, HOMA‐IR, total‐, and LDL‐cholesterol values. Another meta‐analysis of curcumin supplementation indicated a significant decrease of FPG, insulin resistance, and total cholesterol in patients with MetS (Fraser & Price, 1990).…”
Section: Discussionsupporting
confidence: 93%
“…In addition, there is evidence supporting the beneficial metabolic effects of curcumin supplementation. Previously, a meta‐analysis revealed that supplementation with this nutraceutical improved the parameters of insulin metabolism and some lipid fractures in patients with nonalcoholic fatty liver disease (NAFLD) (Jalali et al, 2020). Another meta‐analysis illustrated that taking curcumin containing supplements led to a significant decrease in the levels of some inflammatory indicators and oxidative stress biomarkers in individuals with metabolic syndrome (MetS) (Tabrizi et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Despite the poor bioavailability of curcumin, a few recent meta-analyses described that curcumin/turmeric alleviated hepatic steatosis [ 201 ] and positivelyinfluencedliver-related outcomes, like ALT and AST (especially in doses higher than 1000 mg/day) [ 202 , 203 ]. Jalali et al [ 204 ], in ameta-analysis (n-9 RCTs), aimed to investigate the effects of curcumin on NAFLD and concluded that curcumin-based interventions resulted in ALT, AST, TC, LDL, FBS, HOMA-IR, and serum insulin reduction, but had no effects on the TG, HDL, HbA1c, body weight, and BMI.…”
Section: New Dietary Perspectives In Nafld Treatment Via Gm Modulamentioning
confidence: 99%
“…In recent years, several natural products showed strong nephroprotective activity [ 10 , 11 , 12 , 13 ]. Curcumin (CUR), the Curcuma longa Linn yellow pigment, has attracted much attention for medicinal purposes in a wide range of illnesses such as autoimmune diseases [ 14 ], cancer [ 15 ], diabetes mellitus [ 16 ], and fatty liver disease [ 17 , 18 ]. CUR has a potent antioxidant [ 19 , 20 ], anti-inflammatory [ 14 ], antiproliferative [ 21 , 22 ], immunostimulant [ 23 ], and neuroprotective activities [ 4 , 24 ].…”
Section: Introductionmentioning
confidence: 99%